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Abstract
Background: Obstetric complications have long been retrospectively associated with a wide range of short- and
long-term health consequences, including neurodevelopmental alterations such as those observed in schizophrenia
and other psychiatric disorders. However, prospective studies assessing fetal well-being during pregnancy tend to
focus on perinatal complications as the final outcome of interest, while there is a scarcity of postnatal follow-up
studies. In this study, the cerebroplacental ratio (CPR), a hemodynamic parameter reflecting fetal adaptation to
hypoxic conditions, was analyzed in a sample of monozygotic monochorionic twins (60 subjects), part of them with
prenatal complications, with regard to (i) epigenetic age acceleration, and (ii) DNA methylation at genes included in
the polygenic risk score (PRS) for schizophrenia, and highly expressed in placental tissue.
Results: Decreased CPR measured during the third trimester was associated with epigenetic age deceleration (β =
0.21, t = 3.362, p = 0.002). Exploration of DNA methylation at placentally expressed genes of the PRS for
schizophrenia revealed methylation at cg06793497 (EP300 gene) to be associated with CPR (β = 0.021, t = 4.385; p
= 0.00008, FDR-adjusted p = 0.11). This association was reinforced by means of an intrapair analysis in monozygotic
twins discordant for prenatal suffering (β = 0.027, t = 3.924, p = 0.001).
Conclusions: Prenatal adverse environment during the third trimester of pregnancy is associated with both (i)
developmental immaturity in terms of epigenetic age, and (ii) decreased CpG-specific methylation in a gene
involved in hypoxia response and schizophrenia genetic liability.




Prenatal environment constitutes the first modulating agent
the developing fetus encounters as it progresses through
gestation. The tremendous impact of any environmental
threat occurring during this period for both short- and
long-term consequences is now widely accepted and
well-known as the Developmental Origins of Health and
Disease (DOHaD) hypothesis [1]. Also known as the theory
of fetal programming, the embedding of early life and its
ability to exert long-term effects in late-life is thought to
rely on epigenetic mechanisms [2, 3].
Recently, several DNA methylation-based epigenetic
clocks have been developed in order to predict chrono-
logical age with high accuracy [4, 5]; afterward, Knight
and colleagues developed a new predictor specifically
aimed to predict gestational age (GA) in perinatal sam-
ples [6]. Although epigenetic and chronological age
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robustly show high correlation across studies, the differ-
ence between both variables allows the estimation of the
so-called age acceleration (i.e., when epigenetic age is
higher than chronological age).
On the one hand, epigenetic age acceleration in adult
subjects has been associated with cumulative lifetime
stress, lifestyle, and all-cause mortality, among others,
suggesting its utility as a better predictor for life expect-
ancy than chronological age itself [7–9]. On the other
hand, epigenetic GA deceleration (i.e., when chrono-
logical age is higher than epigenetic age), as measured in
cord blood, has been described in newborns born to
women with low socioeconomic status, Sjögren syn-
drome, insulin-treated gestational diabetes mellitus, and
experiencing antenatal depressive symptoms [6, 10, 11].
Such findings suggest that newborns exposed to prenatal
stressors are born in an immature state independently of
their chronological GA. In this regard, boys—but not
girls—who exhibited lower epigenetic GA at birth exhib-
ited more internalizing problems, such as
anxious-depressive symptoms or somatic complaints, at
follow-up (mean age 3.7 years), suggesting they are born
with a developmental disadvantage [11].
Nevertheless, there is a dearth of studies examining
the putative relationship between ultrasound parameters
acquired during pregnancy and epigenetic GA acceler-
ation. In this regard, the cerebroplacental ratio (CPR)
has been reported to be associated with adverse perinatal
outcomes not only in growth-restricted fetuses, but also
in low-risk population [12, 13]. Briefly, CPR is calculated
by dividing the middle cerebral artery (MCA) pulsatility
index (PI) by the umbilical artery (UA) PI [14]. The PI is
a parameter reflecting vascular impedance or resistance,
i.e., decreased blood flow. Specifically, fetal brain blood
supply is known to increase in front of hypoxic stimuli
thus decreasing PI in the MCA [15]; while placental in-
sufficiency decreases umbilical blood flow hence increas-
ing UA PI, and has been associated with both short- and
long-term detrimental outcomes, including increased
cardiovascular risk and deficits in cognition [16, 17].
Consequently, a decreased CPR reflects the combination
of both alterations and is an indicator of fetal adaptation
to adverse conditions [12].
Obstetric complications (OCs) constitute one of the
risk factors more reliably associated with psychopath-
ology, particularly with neurodevelopmental disorders;
specifically, the putative association between OCs and
schizophrenia has been debated since the 1970s [18–20].
In this regard, a recent umbrella review evaluating all
published meta-analysis regarding risk factors and bio-
markers for schizophrenia spectrum disorders revealed a
history of OCs to significantly increase the risk for de-
veloping the disorder with an odds ratio of 2 [21]. Fur-
thermore, exposure to severe OCs together with
increased genetic vulnerability, as measured with the
polygenic risk score (PRS) for schizophrenia, interact to
increase the risk to suffer the disorder up to an odds ra-
tio of 8.36 [22]. In the same study, authors further ex-
plored the putative relevance of placental expression of
genes included in the PRS; following this approach, they
reported (i) an enrichment of PRS genes expressed in
placental tissue and (ii) differential expression of PRS
genes in placentae from complicated pregnancies (spe-
cifically in pre-eclampsia and intrauterine growth restric-
tion). Specifically, the described gene-environment
interaction between exposure to OCs and the PRS for
schizophrenia was driven by those genes highly
expressed in placenta and/or dynamically regulated in
complicated pregnancies [22]. Since CPR is a robust in-
dicator of prenatal stress and a predictor of perinatal
and long-term morbidity, DNA methylation analysis of
genes included in the placental PRS for schizophrenia
could shed light on the epigenetic mechanisms mediat-
ing the interaction between OCs and neurodevelopmen-
tal disorders.
Monozygotic twins have been instrumental for the elu-
cidation of environmental and genetic risks in the eti-
ology of complex traits and disorders. Actually, the
differential role of the prenatal environment in shaping
psychopathological proneness was first described thanks
to monozygotic twin designs [23–25]; these pioneering
studies focused on dermatoglyphic measures assessed at
birth, which can be used as surrogate measures of al-
tered neurodevelopment during the second trimester of
pregnancy [26]. Furthermore, monozygotic twin preg-
nancies and, more specifically, monochorionic twin
pregnancies—i.e., those in which both fetuses share the
placenta—are at a higher risk of obstetric complications,
the more prevalent being twin-to-twin transfusion syn-
drome (TTTS) and selective intrauterine growth restric-
tion (sIUGR) [27–29]. Thus, the thorough and
prospective ultrasound assessment of prenatal develop-
ment through monochorionic twin pregnancies offers a
quasi-experimental study design in which the genetic
and environmental components of epigenetic variability
can be dissected.
The objective of the current study was to investigate
whether prenatal adverse environment (i) alters human
development in terms of epigenetic age, and if (ii) it can
get embedded through epigenetic mechanisms in genes
previously identified as risk factors for schizophrenia
acting during prenatal stages. We hypothesized that a
higher exposure to prenatal adverse environment would
be associated with (i) delayed development and (ii) DNA
methylation at genes involved in the pathogenesis of
schizophrenia. While CPR can have diverse effects on
genome-wide DNA methylation, with potential relevance
for a multitude of phenotypes, the present study a priori
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examined how CPR epigenetically regulates risk genes
for schizophrenia, previously described to interact with
the presence of OCs [22].
Results
GA estimation using Knight’s epigenetic clock
After exclusion of two twin pairs (see Methods section),
the final sample size was 30 twin pairs. The mean GA at
birth of our twin cohort (n = 30 twin pairs) was 35.3
weeks (range = 31.7–37.1) and the mean DNA methyla-
tion GA at birth was 35 weeks (range = 31.4–37.7). To
validate the epigenetic clock predictor in our sample,
DNA methylation-based GA was tested for correlation
with chronological GA (r = 0.76, p = 1.68 × 10−12; Fig.
1). The average absolute difference between epigenetic
GA and chronological GA—hereinafter referred as
ΔGA—was 0.9 weeks (range = 0.03–4.02), i.e., 6.3 days.
In agreement with previous studies, there was a signifi-
cant negative correlation between ΔGA and chrono-
logical GA (r = − 0.47; p < 0.001).
Association between ΔGA and CPR
ΔGA was tested for associations with CPR measured
during the third trimester (mean = 33.8 weeks, range =
28.3–36.4), a few days before childbirth (median = 6.5
days). CPR was significantly associated with ΔGA (β =
0.21, t = 3.362, p = 0.002) when adjusting for sex, birth-
weight, diagnostic of either TTTS or sIUGR, surgery
time interval (when laser fetoscopy had been applied),
and gestational age at ultrasound as covariates. The posi-
tive association between CPR and ΔGA remained signifi-
cant after correction for cell type proportion (β = 0.21, t
= 2.616, p = 0.01). Figure 2 shows the positive associ-
ation between third trimester CPR and ΔGA.
Epigenetic exploration of placental PRS for schizophrenia
with regard to CPR
Following the approach developed by Ursini and collab-
orators (2018), association between CPR and DNA
methylation was tested in all CpG sites included in the
DNA methylation array located within genes of the PRS
for schizophrenia expressed in placental tissue (placental
PRS) [22]. There were 1400 CpG sites annotated to pla-
cental PRS genes out of 866,091 CpG sites included in
the array. After FDR correction for multiple testing,
methylation at one single CpG site, cg06793497, was sig-
nificantly associated with CPR (β = 0.021, p = 0.00008, t
= 4.385; qFDR adjusted = 0.11; Fig. 3a), such that increased
Fig. 1 Correlation between chronological GA and epigenetic GA. Chronological GA was calculated using first-trimester crown-rump length
measurement of the larger twin, and epigenetic age was calculated based on DNA methylation-based Knight’s clock. Both GA estimations were
significantly correlated (r = 0.76; p = 1.68 × 10−12)
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cg06793497 methylation was associated with increased
CPR. The top 10 CpG sites yielded by this approach are
summarized in Table 1 (all q values > 0.75).
To further explore the association between
cg06793497 methylation and CPR, it was analyzed in a
monozygotic twin intrapair design. The intrapair twin
design further allows controlling for chronological GA,
sex, and timing of the Doppler ultrasound, since these
variables are shared by co-twins of a pair. Four observa-
tions were removed from the analysis due to missingness
for any of the variables in one of the co-twins of a pair.
Thus, intrapair differences for these measures were cal-
culated for all twin pairs of the sample were both mea-
sures were available for both twins of a pair (n = 27 twin
pairs). Intrapair differences in cg06793497 methylation
and CPR, measured during the third trimester, were sig-
nificantly correlated (r = 0.64, p < 0.001; Fig. 3b). The
association between both variables remained significant
after adjusting for cell type count intrapair differences (β
= 0.027, t = 3.924, p = 0.001). Intrapair exploration of
the top 10 CpG sites (Table 1) revealed significant asso-
ciations between CPR and DNA methylation at CpG
probes cg00262246 (β = 0.012, p = 0.029), cg01024069
(β = − 0.01, p = 0.033), and cg12955069 (β = − 0.021, p =
0.026).
DNA methylation exploration of EP300 gene
To further explore the putative relevance of DNA
methylation at other CpG sites located within the EP300
gene and its surrounding regions, DNA methylation at
27 CpG sites included in the array and annotated to this
region was also explored with regard to CPR (see Table
2). All analyses were adjusted for cell sex, birthweight,
gestational age at ultrasound, and cell type count. In
addition to cg06793497, two additional CpG sites—
cg12968540 and cg19011939—were significantly associ-
ated with CPR (p < 0.05); moreover, methylation at four
additional CpG sites—cg04452260, cg24349919,
cg11931284 and cg25888227—showed trend associations
with CPR (p < 0.01). The intrapair approach was then
applied for these newly identified six CpG sites revealing
cg11931284 (β = 0.028, t = 2.985, p = 0.008) and
cg19011939 (β = − 0.021, t = − 2.343, p = 0.03) to be sig-
nificantly associated with CPR, when adjusting for cell
types intrapair differences.
Fig. 2 Association between epigenetic age acceleration and cerebroplacental ratio measured during the third trimester. Epigenetic age delta
(ΔGA) corresponds to estimated epigenetic age minus chronological age. Thus, ΔGA-positive values reflect epigenetic age acceleration while
negative values point out the presence of epigenetic age deceleration. The cerebroplacental ratio (CPR) is calculated as the ratio between the
MCAPI and UAPI. Both variables were significantly correlated when adjusting for sex, chronological gestational age, birth weight, and gestational
age at ultrasound
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Discussion
To the best of our knowledge, this is the first study ana-
lyzing the epigenetic age in association with adverse pre-
natal environment as measured by a hemodynamic
ultrasound parameter. Firstly, we describe the significant
association between CPR measured during the third tri-
mester of pregnancy with epigenetic age acceleration.
Specifically, subjects exhibiting decreased CPR—exposed
to prenatal adverse conditions—were born with deceler-
ated epigenetic age, i.e., prenatally stressed subjects were
born immature adjusting for their gestational age at
birth. Additionally, methylomic exploration of schizo-
phrenia PRS genes known to be expressed in placenta
revealed the association between CPR and EP300 gene
CpG-specific methylation, at the cg06793497 probe, in
our monochorionic twin sample.
Fig. 3 Schizophrenia PRS methylation exploration with regard to cerebroplacental ratio measured during the third trimester. a Methylation at
cg06793497 (EP300 gene) was significantly associated with CPR in the whole sample (n = 54 twin subjects). b Intrapair methylation difference at
cg06793497 was significantly associated with intrapair CPR difference (n = 26 twin pairs)
Table 1 Top 10 CpG sites of the PRS methylomic exploration in association with CPR (1400 CpG sites tested)
# CpG probea Genomic
coordinatesb
Gene PRS explorationc Intrapaird
beta p value q value beta p value
1 cg06793497 22: 41,542,898 EP300 0.021 8.2E-05 0.115 0.027 0.001
2 cg15620905 1: 44,024,150 PTPRF 0.040 0.002 0.804 0.008 0.563
3 cg12252443 2: 198,364,630 HSPD1 -0.006 0.002 0.804 − 0.007 0.055
4 cg24936500 2: 233,499,637 EFHD1 0.022 0.004 0.804 0.001 0.849
5 cg00262246 3: 136,007,461 PCCB 0.012 0.004 0.804 0.012 0.029
6 cg22495590 5: 138,161,059 CTNNA1 -0.020 0.004 0.804 − 0.010 0.203
7 cg14902598 5: 138,210,650 CTNNA1 0.017 0.005 0.804 0.006 0.371
8 cg01024069 14: 104,158,878 KLC1 -0.010 0.005 0.804 − 0.010 0.033
9 cg16362480 16: 30,077,084 ALDOA 0.031 0.005 0.804 0.024 0.126
10 cg12955069 16: 58,593,852 CNOT1; SNORA50 -0.016 0.006 0.804 − 0.021 0.026
a CpG site code according to the Illumina annotation
bGenomic coordinates correspond to hg19 built
cRefers to the statistics of each analysis in the first model encompassing 1400 CpG sites located in genes of the PRS for schizophrenia highly expressed in the
placenta as described by Ursini et al.
dRefers to intrapair comparison of DNA methylation values and CPR. Thus, the n for these analyses was of 26 twin pairs
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Developmental deficits and developmental delays
have been previously described in children who would
later develop schizophrenia [30]; although such pro-
dromal symptoms were in accordance with the neuro-
developmental hypothesis for schizophrenia, biological
mechanisms mediating these effects remain largely
unknown. Epigenetic immaturity in response to pre-
natal stress could be contributing to this developmen-
tal delay. Interestingly, epigenetic age deceleration has
been previously described in association with maternal
pathologies during pregnancy, such as maternal de-
pression or Sjögren’s syndrome, suggesting it can be a
robust biomarker of prenatal suffering [10, 11]. It is
worth noting that CPR was measured a few days
prior to childbirth; thus, it can be used as a surrogate
marker of prenatal adaptation to adverse conditions
experienced at the end of the pregnancy, i.e., as a
marker of perinatal risk.
Integration of the schizophrenia PRS [31] with obstet-
ric and placental information [22], allowed the identifi-
cation of E1A binding protein p300 (EP300) gene
CpG-specific methylation as a putative marker of expos-
ure to prenatal stress. Interestingly, the EP300 gene en-
codes a histone acetyltransferase (HAT) involved in
several cell pathways such as cell proliferation and differ-
entiation. Mutations at EP300 gene have been described
to cause Rubinstein-Taybi syndrome, a rare autosomal
dominant neurodevelopmental disorder characterized by
intellectual disability, psychomotor and language delay,
and facial dysmorphisms [32]. Likewise, these symptoms,
including developmental delay, learning problems, and
cleft palate, characterize the 22q11.2 deletion syndrome,
a well-defined congenital condition caused by the dele-
tion of the 22q11.2 segment [33]. Notably, this syndrome
is associated with a higher risk to develop schizophrenia,
among other psychiatric conditions [34]; interestingly,
EP300 gene is located on chromosome 22 at position
22q13.2.
Further exploration of differential DNA methylation in
and around the EP300 gene revealed cg19011939 to be
differentially methylated in association with prenatal ad-
versity. While higher exposure to a prenatal adverse en-
vironment, as reflected by lower CPR during the third
trimester, is associated with decreased methylation at
cg06793497 in the hypoxia-responsive EP300 gene, there
appears to be increased methylation at cg19011039 at
EP300-AS1 gene. Thus, we speculate that higher expos-
ure to prenatal stress might be associated with reciprocal
patterns of EP300 and EP300-AS1 epigenetic regulation
that could act synergistically, a hypothesis that may be
explored in future studies [35].
Remarkably, EP300 has been identified as a
co-activator of the hypoxia-inducible factor 1 alpha
(HIF1A). In this regard, hypoxic conditions stimulate
EP300 expression, which has a neuroprotective role [36].
Accordingly, genetic variability at EP300 gene has been
associated with human adaptations to high altitude re-
gions, e.g., the Tibet [37]. Likewise, pre- and peri-natal
hypoxia have been associated with schizophrenia
spectrum disorders, particularly by decreasing hippo-
campal volume [38, 39]; complementarily, a decreased
or impaired response to hypoxia via neurotrophic factors
has also been implicated in the etiology of schizophrenia
[40]. Furthermore, DNA methylation at the IGF2BP1
gene, also involved in prenatal development [41], has
been associated with both adult working memory and
birthweight [42]; further highlighting the advantage of
twin study designs to identify environmentally-driven
epigenetic consequences of prenatal stress. Overall, these
findings point to the existence of a GxE interaction be-
tween genetic vulnerability and exposure to prenatal
hypoxia, as already highlighted by Ursini and
Table 2 List of CpG sites included in the array located in the
EP300 gene and its surrounding CpG island and antisense
ncRNA (EP300-AS1)
CpG probe Genomic coordinates beta p value
cg00500400 41487283 0.001 0.67
cg04452260 41487569 0.003 0.09
cg09331127 41487734 − 0.0006 0.79
cg02046995 41487740 0.004 0.49
cg24349919 41487761 0.005 0.09
cg02107564 41488750 − 0.005 0.48
cg03427564 41489051 0.004 0.21
cg03656483 41490340 − 0.001 0.65
cg00187244 41492007 0.011 0.23
cg11931284 41492370 0.015 0.07
cg13028324 41501680 − 0.0005 0.89
cg20730595 41513219 − 0.001 0.85
cg17439569 41513539 − 0.005 0.16
cg05997318 41542772 − 0.014 0.12
cg06793497 41542898 0.021 0.00008
cg06329185 41544246 − 0.0008 0.75
cg07345240 41556691 0.002 0.73
cg25299898 41563501 0.003 0.74
cg12968540 41572924 0.009 0.008
cg26901641 41573032 − 0.006 0.12
cg03950371 41573046 − 0.003 0.48
cg14455139 41573155 − 0.0001 0.98
cg05601844 41573176 − 0.0005 0.89
cg19011939 41591607 − 0.01 0.01
cg12917725 41592634 0.002 0.76
cg25888227 41593581 0.004 0.07
cg22037654 41593650 0.0001 0.94
DNA methylation at CpG sites highlighted in italics was significantly associated
with CPR measured during the third trimester in an intrapair approach
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collaborators [22]. In this framework, EP300 methylation
could be one of the mediators of such interaction.
A number of limitations of the present study should
be noted. First, the moderate sample size (n = 60 sub-
jects, 30 twin pairs) limits the statistical power of the
analysis; however, smaller sample sizes (n = 22 MZ twin
pairs) have been described to be sufficient to identify
methylation differences of 6% with > 80% power [43].
Moreover, a lenient significance threshold after correc-
tion multiple testing was used; however, previous epi-
genetic studies have described FDR values between 5
and 20% as markers of medium-confidence sites [44].
Another limitation regards the moderately small re-
ported effect sizes (around 2%) questioning the bio-
logical relevance of our findings [45]; however, these
findings are in agreement with a larger body of evidence
regarding cord blood methylation after exposure to a
number of prenatal stressors. Such small DNA methyla-
tion changes may act in conjunction with a myriad of
other epigenetic signatures and biological processes in
order to maintain homeostasis in the face of threats.
Additionally, although epigenomic information was
available from a methylomic array including more than
800,000 CpG sites distributed throughout the whole hu-
man genome, only 1400 CpG sites were analyzed; alter-
native approaches including the total of CpG sites
included in the array would have yield different findings,
probably pointing to genes involved in other neurodeve-
lopmental disorders besides schizophrenia. Furthermore,
while the set of genes analyzed in the current approach
were described to be highly expressed in placental tissue
[22], placentae were not available for this sample and
cord blood was thus analyzed as the proxy tissue of
choice with regard to exposure to prenatal adversity. Fi-
nally, MZ twin pregnancies are characterized by lower
gestational ages at birth than singleton pregnancies; be-
sides, obstetric scales commonly used in psychiatric
studies include twin pregnancies as an obstetric compli-
cation. Thus, findings derived from the present design
might not be generalizable to the general population.
Conclusions
Further studies are needed to test the time stability of
the hereby identified methylation signature. It will be
equally relevant to explore neurobehavioral correlates of
EP300 methylation during early childhood along with its
putative association with neurodevelopmental outcomes,
including psychosis liability. Additionally, a longitudinal
follow-up is required to test the role of postnatal envir-
onment in these phenotypes since both epigenetic age
deceleration and CpG-specific differential methylation in
association with CPR could return to basal levels after
birth. Finally, genetic exploration of these subjects re-
garding schizophrenia PRS will be instrumental for the
study of GxE interactions and genetic liability for an im-
paired hypoxia response during human development.
Methods
Study population
This was a prospective study including fetal pairs from
monochorionic diamniotic twin pregnancies attended at
Hospital Clínic de Barcelona (Spain) during a 2-year re-
cruitment period. Monochorionic monoamniotic twin
pregnancies were excluded from the present study to
avoid putative confounding with regard to differential
exposure to stress in both types of twin pregnancies.
The study protocol was approved by the hospital ethics
committee (HCB/2016/0046), and all patients provided
written informed consent.
We included 32 monochorionic pregnancies (n = 64
samples). The sample was enriched for two
monochorionic-specific severe obstetric complications:
twin-to-twin transfusion syndrome (TTTS, n = 8) and
selective intrauterine growth restriction (sIUGR, n = 9).
All TTTS cases were treated upon detection by means
of laser fetoscopy [46].
Maternal age and pre-pregnancy BMI were retrieved
from hospital records. Gestational age was dated using
first-trimester crown-rump length measurement of the
larger twin [47].
Fetal ultrasound assessment
Ultrasound assessment was performed on a Voluson Ex-
pert 8 (General Electrical Medical Systems, Milwaukee,
WI, USA) or a Siemens Sonoline Antares (Siemens
Medical Systems, Erlangen, Germany) with 8- to 4-MHz
or 6- to 4- MHz curved array probes, respectively. All
fetuses underwent detailed ultrasound evaluation includ-
ing fetal anatomy and Doppler measurements such as
UAPI, MCAPI and ductus venosus PI. All Doppler eval-
uations were acquired at a normal fetal heart rate (FHR)
in the absence of fetal body or respiratory movements
and at an angle of insonation as close to 0° as possible
(but always < 15°), and the mechanical and thermal indi-
ces were maintained below 1. CPR was calculated as the
ratio between MCAPI and UAPI, according to previous
studies [12].
DNA methylation
Umbilical vein cord blood samples were obtained from
the clamped umbilical cord immediately after delivery of
the fetus. All blood samples were collected in
EDTA-treated tubes and processed within 1 h. Plasma
was separated by centrifugation at 3000 rpm for 10 min
at 4 °C, and stored at − 80 °C until further use. Genomic
DNA was extracted from fetal cord blood using QIAamp
DNA Mini Kit (Qiagen). DNA quality and quantity were
assessed by NanoDrop One (Thermo Scientific).
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Genomic DNA was bisulfite converted using the Zymo
EZ-96 DNA Methylation Kit (Zymo Research).
Genome-wide DNA methylation levels were assessed
over 850,000 CpG sites by means of the Infinium Methy-
lationEPIC BeadChip Kit (Illumina Inc., CA, USA) ac-
cording to the manufacturer’s protocol. Pre-processing
and normalization were performed using the Bioconduc-
tor minfi package [48]. CpG probes containing common
SNPs were discarded. All probes mapping to the X and
Y chromosomes were also removed. Finally,
cross-hybridizing probes as previously identified were
excluded from further analysis [49]. All samples (n = 64)
were run on the same plate.
Absence of maternal contamination was confirmed
after retrieving DNA methylation values at 10 CpG sites
previously described to identify sample contamination
by maternal blood during sample collection [50]. None
of the samples assayed exhibited DNA methylation
values above the threshold at 5 or more of those CpG
sites (see Additional file 1 for specific methylation
values). Two samples (from the same twin-pair) were ex-
cluded from further analyses due to lack of monozygos-
ity as assessed by 59 SNPs included in the array. One of
the samples was removed from analysis due to insuffi-
cient DNA concentration, the co-twin sample was also
excluded from further analysis.
Statistical analyses
All statistical analyses were conducted in R version 3.5.0
[51]. DNA methylation-based GA prediction was per-
formed using the R code and statistical pipeline devel-
oped by Knight, based on the methylation profile of 148
CpG sites [6]; this predictor was developed using 15 Illu-
mina DNA methylation datasets (n = 1434 neonates).
Following Simpkin et al. recommendations, the Knight
clock was preferred for our analysis as it was developed
and tested in preterm infants datasets such as our
monozygotic twin population, characterized by a mean
gestational age at birth of 35.3 weeks [52]. The EPIC
array lacks 6 of the CpG sites originally included in the
Knight clock, these values were imputed manually as
non-available. Interestingly, DNA methylation-based age
estimation relying on EPIC array data has already been
described to accurately predict age despite the lack of
several CpG sites originally included in Horvath’s and
Hannum’s clocks [53].
Gestational age acceleration (ΔGA) was calculated as
the absolute difference between epigenetic GA and
chronological GA. Since ΔGA was associated with
chronological GA (r = − 0.47; p < 0.001), the latter was
included as a covariate in all statistical models; this asso-
ciation has been already reported in prior studies explor-
ing epigenetic-based GA estimations at birth [6, 10, 11].
Cell counts of CD4+ T cells, CD8+ T cells, B cells, NK
cells, granulocytes, monocytes, and nucleated red blood
cells (nRBCs) were estimated using the R code and stat-
istical pipeline developed by Houseman [54].
A multiple linear regression model was built to analyze
the correlation between ΔGA and CPR. Fetal sex, birth-
weight, diagnostic of either TTTS or sIUGR (binary vari-
able), post-surgery interval (in TTTS cases where laser
fetoscopy had been applied), and gestational age at ultra-
sound were included as independent variables in the
model as they are known to influence either DNA
methylation (from which ΔGA is calculated) or CPR.
This analysis was conducted in the total MZ twin sample
(n = 60).
DNA methylation at CpG sites annotated to the 43
genes of the Placental PRS1 as described by Ursini et al.
[22] was retrieved to test their association with CPR. A
second multiple linear regression model was then de-
signed to explore putative effects of CPR upon methyla-
tion of PRS genes, testing 1,400 associations. The
aforementioned confounding variables along with cell
types proportions (CD4+ T cells, CD8+ T cells, B cells,
NK cells, granulocytes, monocytes, and nRBCs) were in-
cluded as covariates, as they are known to affect methy-
lation values. False discovery rate (FDR) correction for
multiple testing was applied, considering q values under
20% to be indicative of medium-confidence probes fol-
lowing prior studies [44].
A twin-based approach previously developed in our
group [55] was also applied to refine the association be-
tween cg06793497 methylation and CPR. Briefly, intra-
pair differences for both variables of interest were
computed for each twin pair; afterward, a regression
model was fitted with an estimated intrapair cg06793497
methylation (Δmethylation) and intrapair CPR (ΔCPR).
This last model was not adjusted for either sex or
chronological gestational age since both variables are
identical for both twins of a pair.
Additional file
Additional file 1: DNA methylation values for CpG probes used to
discard the presence of maternal contamination. (DOCX 29.6 kb)
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